Overview
Lobbying Costs
75,000€
Financial year: Jan 2020 - Dec 2020
Lobbyists (Full time equivalent)
0.5 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Cerus Europe B.V.
EU Transparency Register
904126942034-93 First registered on 05 Apr 2021
Goals / Remit
Cerus Corporation is dedicated solely to safeguarding the world’s blood supply. The company develops and supplies vital technologies to pathogen-protect blood components for blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components.
Main EU files targeted
Blood, tissues and cells for medical treatments & therapies
EU4HealthAddress
Head Office
Stationsstraat 79-D
Amersfoort 3811 MH
NETHERLANDS -
People
Total lobbyists declared
2
Employment time Lobbyists 25% 2 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 05 Apr 2021
Name Start date End Date Ms Kathleen ROWE 21 Apr 2023 26 Apr 2024 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
https://www.medtecheurope.org/
https://www.bvmed.de/de/englishMember organisations
None declared
-
Financial Data
Closed financial year
Jan 2020 - Dec 2020
Lobbying costs for closed financial year
75,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
None
Other activities
None declared
Meetings
Meetings
None declared